Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Stanley C. Rall"'
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 11, Pp 1933-1949 (1999)
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and development of premature atherosclerosis. Although receptor binding-defective forms of apolipoprotein (apo) E are the co
Externí odkaz:
https://doaj.org/article/a3fb3d834e794e398486527d191caa1f
Autor:
Zhong-Sheng Ji, Robert W. Mahley, Yadong Huang, John M. Taylor, Walter J. Brecht, Stanley C. Rall
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 19:2952-2959
Abstract —The differential effects of overexpression of human apolipoprotein (apo) E3 on plasma cholesterol and triglyceride metabolism were investigated in transgenic rabbits expressing low (20 mg/dL) levels of apoE3. Cholesterol levels increased
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 11, Pp 1933-1949 (1999)
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and development of premature atherosclerosis. Although receptor binding-defective forms of apolipoprotein (apo) E are the co
Publikováno v:
Journal of Biological Chemistry. 272:22685-22694
Transgenic rabbits were produced that expressed high plasma levels (30–70 mg/dl) of human apolipoprotein (apo) E2(Cys-158), an apoE variant associated with the human genetic disorder type III hyperlipoproteinemia (HLP). Male transgenic rabbits fed
Publikováno v:
Journal of Biological Chemistry. 271:29146-29151
Transgenic mice were produced that expressed different plasma levels (3-60 mg/dl) of human apolipoprotein (apo) E2(Arg158 --Cys), which is associated with the recessive form of human type III hyperlipoproteinemia (HLP). In transgenic mice fed a norma
Publikováno v:
Journal of Biological Chemistry. 269:32368-32372
Despite the definite etiologic link between apolipoprotein (apo) E mutations and type III hyperlipoproteinemia (HLP), it is not clear what additional factors are involved in the development of florid hyperlipidemia and how to explain the wide variabi
Publikováno v:
Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:1873-1879
Transgenic mice expressing apolipoprotein (apo) E(Cys 142), a human defective variant of apo E, have elevated levels of plasma cholesterol, triglycerides, and very-low-density lipoproteins (VLDL); beta-VLDL, the biochemical hallmark of the human gene
Publikováno v:
Journal of Lipid Research, Vol 35, Iss 3, Pp 408-416 (1994)
Transgenic mouse lines were produced that expressed low levels of a receptor-binding-defective variant of human apolipoprotein (apo) E, apoE(Arg112, Cys142). In transgenic mice, the human apoE was produced only by the kidney, whereas endogenous mouse
Autor:
Robert W. Mahley, Stanley C. Rall
Publikováno v:
Journal of Internal Medicine. 231:653-659
Apolipoprotein E plays a central role in lipoprotein metabolism by serving as a ligand for the binding of lipoproteins to lipoprotein receptors. Both common and rare variants of apoE have been described. The common variants apoE2 and apoE4 have a sig
Publikováno v:
Journal of Biological Chemistry. 267:6941-6945
The synthesis and secretion of apolipoprotein (apo) E, a major protein component of very low density lipoproteins, were examined in the human hepatoma cell line HepG2 under metabolic conditions known to stimulate lipogenesis and the production of apo